Holen Sie sich die Stockscreener-App
28.93
7.63%
2.05
Handel nachbörslich:
28.93
Schlusskurs vom Vortag:
$26.88
Offen:
$26.77
24-Stunden-Volumen:
415.28K
Relative Volume:
0.55
Marktkapitalisierung:
$1.06B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+11.57%
1M Leistung:
-2.59%
6M Leistung:
+152.66%
1J Leistung:
+17.94%
1-Tages-Spanne:
$26.43
$29.18
1-Wochen-Bereich:
$25.95
$29.21
52-Wochen-Spanne:
$7.13
$42.27
Rapport Therapeutics Inc Stock (RAPP) Company Profile
Firmenname
Rapport Therapeutics Inc
Sektor
Branche
Telefon
857-321-8020
Adresse
99 HIGH STREET, BOSTON
Vergleichen Sie RAPP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RAPP
Rapport Therapeutics Inc
|
28.93 | 1.24B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-16 | Eingeleitet | Truist | Buy |
| 2025-08-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-08 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-07-02 | Eingeleitet | Jefferies | Buy |
| 2024-07-02 | Eingeleitet | Stifel | Buy |
| 2024-07-02 | Eingeleitet | TD Cowen | Buy |
Alle ansehen
Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten
Historical volatility pattern of Rapport Therapeutics Inc. visualizedJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
Can trapped investors hope for a rebound in Rapport Therapeutics Inc.Market Growth Review & AI Driven Stock Reports - newser.com
Will Rapport Therapeutics Inc. benefit from macro trendsWeekly Earnings Recap & Risk Adjusted Buy/Sell Alerts - newser.com
Has Rapport Therapeutics Inc. formed a bullish divergenceWeekly Trading Summary & Pattern Based Trade Signal System - newser.com
Using R and stats models for Rapport Therapeutics Inc. forecastingJuly 2025 Decliners & Verified Momentum Stock Ideas - newser.com
Tools to monitor Rapport Therapeutics Inc. recovery probabilityTrade Exit Summary & Real-Time Market Sentiment Reports - newser.com
Analyzing Rapport Therapeutics Inc. with risk reward ratio chartsJuly 2025 Institutional & Verified Swing Trading Watchlist - newser.com
What earnings revisions data tells us about Rapport Therapeutics Inc.Quarterly Performance Summary & Long-Term Safe Return Strategies - newser.com
What candlestick patterns are forming on Rapport Therapeutics Inc.July 2025 Update & Low Drawdown Trading Techniques - newser.com
Published on: 2025-10-27 07:18:29 - newser.com
Rapport Therapeutics (RAPP) Expected to Announce Earnings on Thursday - MarketBeat
How to recover losses in Rapport Therapeutics Inc. stock2025 Trading Recap & AI Driven Price Predictions - newser.com
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 8.1%Still a Buy? - MarketBeat
Is Rapport Therapeutics Inc a good long term investmentEconomic Indicators Overview & Outstanding Return Portfolio - earlytimes.in
Published on: 2025-10-28 05:44:22 - newser.com
What to do if you’re stuck in Rapport Therapeutics Inc.July 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Breakout Watch: Can Rapport Therapeutics Inc. stock beat market expectations this quarterTrade Risk Report & Fast Entry and Exit Trade Plans - fcp.pa.gov.br
Published on: 2025-10-27 00:48:27 - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)
Es liegen keine Finanzdaten für Rapport Therapeutics Inc (RAPP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):